Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN | Glomerulonephritis, IGA, Immunoglobulin A Nephropathy | Phase2 | Malaysia
United States | NCT06797518 |
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines | Chronic Spontaneous Urticaria (CSU) | Phase3 | United States | NCT06868212 |
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) | Prostatic Cancer, Castration-Resistant | Phase2 | Singapore | NCT07047118 |
A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease | Difficult-to-treat Rheumatoid Arthritis (RA) and Severe, Refractory Sjögren's Disease (SjD) | Phase1, Phase2 | Singapore | NCT07048197 |
An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis | Rheumatoid Arthritis | Phase1 | China | NCT07029555 |
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia | Atherosclerotic Cardiovascular Disease | | Russian Federation | NCT06858332 |
Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study | Atherosclerotic Vascular Disease, Heterozygous Familial Hypercholesterolemia | | Spain | NCT06958315 |
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD | Atherosclerotic Cardiovascular Disease (ASCVD) | Phase3 | United States | NCT06813911 |
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib | Hematologic Malignancy, Solid Tumor, Advanced Malignancies | Phase3 | Belgium
Italy
NetherlandsUnited Kingdom
United States View All | NCT06401356 |
Home Reported Outcomes in C3G Study | C3 Glomerulopathy | | United States | NCT07029542 |